| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007532724AJP5265190B2 (en) | 2004-09-24 | 2005-09-26 | Pluripotent proliferating mesenchymal progenitor progeny (MEMP) and uses thereof |
| ES10075534TES2710099T3 (en) | 2004-09-24 | 2005-09-26 | Progeny of multipotential expanded mesenchymal precursor cells (MEMP) and their uses |
| KR1020077009300AKR101441026B1 (en) | 2004-09-24 | 2005-09-26 | Amplified pluripotent mesenchymal progenitor cells and their uses |
| TR2019/00968TTR201900968T4 (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell line (memp) and their use. |
| CN201110349075.7ACN102391981B (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| KR1020147004599AKR101536613B1 (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| EP05787106AEP1807510A4 (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| CA002580975ACA2580975A1 (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| AU2005287872AAU2005287872B2 (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof |
| CN2005800402121ACN101506355B (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof |
| CA2866468ACA2866468C (en) | 2004-09-24 | 2005-09-26 | Generating multipotential expanded mesenchymal precursor cell progeny (memp) from mesenchymal progenitor cells (mpc) and stimulation factor |
| PCT/AU2005/001445WO2006032092A1 (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| US11/663,563US20080260694A1 (en) | 2004-09-24 | 2005-09-26 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof |
| EP10075534.7AEP2348105B1 (en) | 2004-09-24 | 2005-09-26 | Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof |
| JP2012179934AJP5927080B2 (en) | 2004-09-24 | 2012-08-14 | Pluripotent proliferating mesenchymal progenitor progeny (MEMP) and uses thereof |
| US13/928,502US20140178991A1 (en) | 2004-09-24 | 2013-06-27 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof |
| US15/847,009US20180237746A1 (en) | 2004-09-24 | 2017-12-19 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof |
| US16/284,878US20190177685A1 (en) | 2004-09-24 | 2019-02-25 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof |
| US17/369,147US20210355447A1 (en) | 2004-09-24 | 2021-07-07 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof |
| US18/521,129US20240101961A1 (en) | 2004-09-24 | 2023-11-28 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof |
| Publication Number | Publication Date |
|---|---|
| AU2004906062A0true AU2004906062A0 (en) | 2004-11-04 |
| Publication | Publication Date | Title |
|---|---|---|
| EP1732462A4 (en) | Electromagnetic treatment of tissues and cells | |
| AU2006272937A8 (en) | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders | |
| IL181305A0 (en) | Combinations for the treatment of diseases involving cell proliferation | |
| IL180589A0 (en) | Use of il-28 and il-29 to treat cancer and autoimmune disorders | |
| ZA200607575B (en) | Optimized expression of HPV 52 L1 in yeast | |
| WO2008106102A9 (en) | Inhibitors of rtp801 and their use in disease treatment | |
| IL180600A0 (en) | Compositions and methods of use for treatment of mammalian diseases | |
| AU2007309650A8 (en) | Soluble TNF receptors and their use in treatment of disease | |
| EP1733045A4 (en) | Design and therapeutic use of adpase enhanced apyrases | |
| AU2004906062A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate smooth muscle tissue II | |
| AU2003214160A8 (en) | Tissue specific signal-plexes to dedifferentiate and redifferentiate cells | |
| AU2004905527A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate smooth muscle tissue | |
| IL177444A0 (en) | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | |
| AU2004906061A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate adipose tissue II | |
| AU2004905528A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate adipose tissue | |
| WO2008124843A9 (en) | Combined use of ultrasound and growth factors to stimulate bone formation | |
| EP1765832B8 (en) | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias | |
| AU2004906060A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate neural and glial tissue II | |
| AU2004905525A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate neural and glial tissue | |
| AU2004906063A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate cartilage and ligamentous tissue II | |
| AU2004905526A0 (en) | Proliferation of mesenchymal precursor cells and tissue specific committed cells and use thereof to generate cartilage and ligamentous tissue | |
| AU2004906277A0 (en) | Use of mesenchymal precursor cells and tissue specific committed cells as immunosuppressive agents | |
| AU2006906149A0 (en) | Use of mesenchymal precursor cells and tissue specific committed cells as immunosuppressive agents | |
| AU2005906069A0 (en) | Use of mesenchymal precursor cells and tissue specific committed cells as immunosuppressive agents | |
| WO2005082356A8 (en) | Use of beta-lapachone for the treatment of lung cancer |